{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:56:40Z","timestamp":1781146600611,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13377-5","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:57:13Z","timestamp":1777114633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subclinical atherosclerosis assessed by cardio-ankle vascular index and carotid intima\u2013media thickness in people living with HIV receiving integrase inhibitor\u2013based tenofovir regimens"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-9226","authenticated-orcid":false,"given":"Asl\u0131","family":"Vatan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1514-1685","authenticated-orcid":false,"given":"O\u011fuz","family":"Karabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5255-0667","authenticated-orcid":false,"given":"Hande","family":"Moral\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7830-6779","authenticated-orcid":false,"given":"Yasin","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2860-2831","authenticated-orcid":false,"given":"Ertu\u011frul","family":"G\u00fc\u00e7l\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3840-4038","authenticated-orcid":false,"given":"Aziz","family":"\u00d6\u011f\u00fctl\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5259-8441","authenticated-orcid":false,"given":"Mehmet B\u00fclent","family":"Vatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"13377_CR1","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1161\/CIRCRESAHA.124.323891","volume":"134","author":"LM Obare","year":"2024","unstructured":"Obare LM, Temu T, Mallal SA, Wanjalla CN. Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease. Circ Res. 2024;134:1515\u201345. [CrossRef] [PubMed].","journal-title":"Circ Res"},{"key":"13377_CR2","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S0140-6736(05)67022-5","volume":"366","author":"JA Sterne","year":"2005","unstructured":"Sterne JA, Hern\u00e1n MA, Ledergerber B, Tilling K, Weber R, Sendi P, Rickenbach M, Robins JM, Egger M. Long-Term Effectiveness of Potent Antiretroviral Therapy in Preventing AIDS and Death: A Prospective Cohort Study. Lancet. 2005;366:378\u201384. [CrossRef] [PubMed].","journal-title":"Lancet"},{"key":"13377_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0140-6736(20)31065-5","volume":"396","author":"KH Mayer","year":"2020","unstructured":"Mayer KH, Molina JM, Thompson MA, Anderson PL, Mounzer KC, De Wet JJ, DeJesus E, Jessen H, Grant RM, Ruane PJ, et al. Emtricitabine and Tenofovir Alafenamide vs Emtricitabine and Tenofovir Disoproxil Fumarate for HIV Pre-Exposure Prophylaxis (DISCOVER): Primary Results from a Randomised, Double-Blind, Multicentre, Active-Controlled, Phase 3, Non-Inferiority Trial. Lancet. 2020;396:239\u201354. [CrossRef] [PubMed].","journal-title":"Lancet"},{"key":"13377_CR4","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/cid\/ciz999","volume":"71","author":"PE Sax","year":"2020","unstructured":"Sax PE, Erlandson KM, Lake JE, Mccomsey GA, Orkin C, Esser S, Brown TT, Rockstroh JK, Wei X, Carter CC, et al. Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials. Clin Infect Dis. 2020;71:1379\u201389. [CrossRef] [PubMed].","journal-title":"Clin Infect Dis"},{"key":"13377_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa1902824","volume":"381","author":"WDF Venter","year":"2019","unstructured":"Venter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M, Serenata C, Akpomiemie G, Qavi A, Chandiwana N, et al. Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. N Engl J Med. 2019;381:803\u201315. [CrossRef] [PubMed].","journal-title":"N Engl J Med"},{"key":"13377_CR6","doi-asserted-by":"publisher","first-page":"758","DOI":"10.7326\/M20-4853","volume":"174","author":"B Venter","year":"2021","unstructured":"Venter B, Mugglin C, Calmy A, Cavassini M, G\u00fcnthard HF, St\u00f6ckle M, Bernasconi E, Schmid P, Tarr PE, Furrer H, et al. Weight and Metabolic Changes after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: A Cohort Study. Ann Intern Med. 2021;174:758\u201367. [CrossRef] [PubMed].","journal-title":"Ann Intern Med"},{"key":"13377_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jiac.2022.10.014","volume":"29","author":"R Sekiya","year":"2023","unstructured":"Sekiya R, Muramatsu T, Ichiki A, Chikasawa Y, Bingo M, Yotsumoto M, Hagiwara T, Amano K, Kinai E. Young Age Is a Key Determinant of Body Weight Gain after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Japanese People Living with HIV. J Infect Chemother. 2023;29:171\u20138. [CrossRef] [PubMed].","journal-title":"J Infect Chemother"},{"key":"13377_CR8","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s40261-021-01081-y","volume":"41","author":"L Brunet","year":"2021","unstructured":"Brunet L, Mallon P, Fusco JS, Wohlfeiler MB, Prajapati G, Beyer A, Fusco GP. Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization. Clin Drug Inves-tig. 2021;41:955\u201365. [CrossRef] [PubMed].","journal-title":"Clin Drug Inves-tig"},{"key":"13377_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/01.STR.0000196964.24024.ea","volume":"37","author":"MW Lorenz","year":"2006","unstructured":"Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid Intima-Media Thickening Indicates a Higher Vascular Risk across a Wide Age Range: Prospective Data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2006;37:87\u201392. [CrossRef] [PubMed].","journal-title":"Stroke"},{"key":"13377_CR10","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1161\/01.CIR.96.5.1432","volume":"96","author":"ML Bots","year":"1997","unstructured":"Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial Infarction: The Rotterdam Study. Circulation. 1997;96:1432\u20137. [CrossRef] [PubMed].","journal-title":"Circulation"},{"key":"13377_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10157-021-02149-x","volume":"26","author":"N Aiumtrakul","year":"2022","unstructured":"Aiumtrakul N, Supasyndh O, Krittayaphong R, Phrommintikul A, Satirapoj B. Cardio-ankle vascular index with renal progression and mortality in high atherosclerosis risk: a prospective cohort study in CORE-Thailand. Clin Exp Nephrol. 2022;26:247\u201356. [CrossRef].","journal-title":"Clin Exp Nephrol"},{"key":"13377_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2015.08.003","volume":"242","author":"N Satoh-Asahara","year":"2015","unstructured":"Satoh-Asahara N, Kotani K, Yamakage H, Yamada T, Araki R, Okajima T, Adachi M, Oishi M, Shimatsu A. Japan Obesity and Metabolic Syndrome Study (JOMS) Group. Cardio-ankle vascular index predicts the incidence of cardiovascular events in obese patients: a multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: JOMS). Atherosclerosis. 2015;242:461\u20138. [CrossRef].","journal-title":"Atherosclerosis"},{"key":"13377_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12933-014-0167-y","volume":"14","author":"M\u00c1 G\u00f3mez-Marcos","year":"2015","unstructured":"G\u00f3mez-Marcos M\u00c1, Recio-Rodr\u00edguez JI, Patino-Alonso MC, Agudo-Conde C, G\u00f3mez-S\u00e1nchez L, Gomez-Sanchez M, Rodr\u00edguez-Sanchez E, Maderuelo-Fernandez JA, Garc\u00eda-Ortiz L, LOD-DIABETES Group. The cardio-ankle vascular index is associated with cardiovascular target organ damage and vascular structure and function in patients with diabetes or metabolic syndrome, as shown in the LOD-DIABETES study: a case series report. Cardiovasc Diabetol. 2015;14:7. [CrossRef] [PubMed].","journal-title":"Cardiovasc Diabetol"},{"key":"13377_CR14","unstructured":"European AIDS Clinical Society. EACS Guidelines. Available online: https:\/\/www.eacsociety.org\/guidelines\/eacs-guidelines. (Accessed on October 4, 2025)."},{"key":"13377_CR15","unstructured":"World Health Organization. Body Mass Index. Available online: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/topic-details\/GHO\/body-mass-index. (Accessed on October 4, 2025)."},{"key":"13377_CR16","unstructured":"T\u00fcrkiye Endokrinoloji ve Metabolizma Derne\u011fi. Diabetes Mellitus ve Komplikasyonlar\u0131n\u0131n Tan\u0131 ve Tedavi K\u0131lavuzu. 2024. Available online: https:\/\/file.temd.org.tr\/Uploads\/publications\/guides\/documents\/diabetesmellitus2024.pdf. (Accessed on October 4, 2025)."},{"key":"13377_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/QAI.0b013e31819367cd","volume":"50","author":"MG Van Vonderen","year":"2009","unstructured":"Van Vonderen MG, Smulders YM, Stehouwer CD, Danner SA, Gundy CM, Vos F, Reiss P, van Agtmael MA. Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophy. J Acquir Immune Defic Syndr. 2009;50:153\u201361. [CrossRef] [PubMed].","journal-title":"J Acquir Immune Defic Syndr"},{"key":"13377_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1161\/ATVBAHA.109.196980","volume":"30","author":"A Simon","year":"2010","unstructured":"Simon A, Megnien JL, Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterio-scler. Thromb Vasc Biol. 2010;30:182\u20135. [CrossRef] [PubMed].","journal-title":"Thromb Vasc Biol"},{"key":"13377_CR19","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1089\/aid.2019.0023","volume":"35","author":"L Aurpibul","year":"2019","unstructured":"Aurpibul L, Srithanaviboonchai K, Rerkasem K, Tangmunkongvorakul A, Sitthi W, Musumari PM. Prevalence of Sub-clinical Atherosclerosis and Risk of Atherosclerotic Cardiovascular Disease in Older Adults Living with HIV. AIDS Res Hum Retroviruses. 2019;35:1136\u201342. [CrossRef] [PubMed].","journal-title":"AIDS Res Hum Retroviruses"},{"key":"13377_CR20","doi-asserted-by":"publisher","first-page":"e020103","DOI":"10.1161\/JAHA.120.020103","volume":"10","author":"T Miyoshi","year":"2021","unstructured":"Miyoshi T, Ito H, Shirai K, Horinaka S, Higaki J, Yamamura S, Saiki A, Takahashi M, Masaki M, Okura T, et al. Predictive Value of the Cardio-Ankle Vascular Index for Cardiovascular Events in Patients at Cardiovascular Risk. J Am Heart Assoc. 2021;10:e020103. [CrossRef] [PubMed].","journal-title":"J Am Heart Assoc"},{"key":"13377_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2261-11-51","volume":"11","author":"T Namekata","year":"2011","unstructured":"Namekata T, Suzuki K, Ishizuka N, Shirai K. Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study. BMC Cardiovasc Disord. 2011;11:51. [CrossRef] [PubMed].","journal-title":"BMC Cardiovasc Disord"},{"key":"13377_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/IBPC.S34423","volume":"6","author":"CK Sun","year":"2013","unstructured":"Sun CK. Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness. Integr Blood Press Control. 2013;6:27\u201338. [CrossRef] [PubMed].","journal-title":"Integr Blood Press Control"},{"key":"13377_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/heartasia-2011-010079","volume":"4","author":"T Yingchoncharoen","year":"2012","unstructured":"Yingchoncharoen T, Limpijankit T, Jongjirasiri S, Laothamatas J, Yamwong S, Sritara P. Arterial stiffness contributes to coronary artery disease risk prediction beyond the traditional risk score (RAMA-EGAT score). Heart Asia. 2012;4:77\u201382. [CrossRef] [PubMed].","journal-title":"Heart Asia"},{"key":"13377_CR24","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.2337\/dc10-2300","volume":"34","author":"M Chiu","year":"2011","unstructured":"Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care. 2011;34:1741\u20138. [CrossRef] [PubMed].","journal-title":"Diabetes Care"},{"key":"13377_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijid.2021.07.030","volume":"110","author":"N Ando","year":"2021","unstructured":"Ando N, Nishijima T, Mizushima D, Inaba Y, Kawasaki Y, Kikuchi Y, Oka S, Gatanaga H. Long-term weight gain after initiating combination antiretroviral therapy in treatment-na\u00efve Asian people living with human immunodeficiency virus. Int J Infect Dis. 2021;110:21\u20138. [CrossRef] [PubMed].","journal-title":"Int J Infect Dis"},{"key":"13377_CR26","doi-asserted-by":"crossref","unstructured":"Mallon PWG, Brunet L, Fusco JS, Prajapati G, Beyer A, Fusco GP, Wohlfeiler MB. Lipid changes after switch from TDF to TAF in the OPERA cohort: LDL cholesterol and triglycerides. Open Forum Infect Dis. 2021;9:ofab621. [CrossRef] [PubMed].","DOI":"10.1093\/ofid\/ofab621"},{"issue":"1","key":"13377_CR27","doi-asserted-by":"publisher","first-page":"e26358","DOI":"10.1002\/jia2.26358","volume":"27","author":"JJ Yoo","year":"2024","unstructured":"Yoo JJ, Jung EA, Kim SG, Kim YS, Kim MJ. Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta-analysis. J Int AIDS Soc. 2024;27(1):e26358. [CrossRef] [PubMed].","journal-title":"J Int AIDS Soc"},{"key":"13377_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00535-020-01750-3","volume":"56","author":"K Suzuki","year":"2021","unstructured":"Suzuki K, Suda G, Yamamoto Y, Furuya K, Baba M, Nakamura A, et al. Tenofovir-disoproxil\u2010fumarate modulates lipid metabolism via hepatic CD36\/PPAR\u2010alpha activation in hepatitis B virus infection. J Gastroenterol. 2021;56:168\u201380. [Cross-Ref] [PubMed].","journal-title":"J Gastroenterol"},{"key":"13377_CR29","first-page":"990","volume":"79","author":"J Damas","year":"2024","unstructured":"Damas J, Munting A, Fellay J, Haerry D, Marzolini C, Tarr PE, Steffen A, Braun DL, Stoeckle M, Bernasconi E, et al. Weight, Anthropometric, and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIV. Clin Infect Dis. 2024;79:990\u20138. [CrossRef] [PubMed].","journal-title":"Clin Infect Dis"},{"key":"13377_CR30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jacbts.2021.10.017","volume":"7","author":"L Kovacs","year":"2022","unstructured":"Kovacs L, Kress TC, Belin de Chantem\u00e8le EJ, HIV. Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women. JACC Basic Transl Sci. 2022;7:410\u201321. [CrossRef] [PubMed].","journal-title":"JACC Basic Transl Sci"},{"key":"13377_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0021-9150(01)00736-5","volume":"162","author":"E Seminari","year":"2002","unstructured":"Seminari E, Pan A, Voltini G, Carnevale G, Maserati R, Minoli L, Meneghetti G, Tinelli C, Testa S. Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors. Atherosclerosis. 2002;162:433\u20138. [CrossRef] [PubMed].","journal-title":"Atherosclerosis"},{"key":"13377_CR32","doi-asserted-by":"publisher","first-page":"e0158999","DOI":"10.1371\/journal.pone.0158999","volume":"11","author":"AG Pacheco","year":"2016","unstructured":"Pacheco AG, Grinsztejn B, Fonseca MJ, Griep RH, Lotufo P, Bensenor I, Mill JG, Moreira RC, Moreira RI, Friedman RK, et al. HIV Infection Is Not Associated with Carotid Intima-Media Thickness in Brazil: A Cross-Sectional Analysis from the INI\/ELSA-Brasil Study. PLoS ONE. 2016;11:e0158999. [CrossRef] [PubMed].","journal-title":"PLoS ONE"},{"key":"13377_CR33","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1161\/01.CIR.0000124480.32233.8A","volume":"109","author":"PY Hsue","year":"2004","unstructured":"Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, Waters DD. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004;109:1603\u20138. [CrossRef] [PubMed].","journal-title":"Circulation"},{"key":"13377_CR34","doi-asserted-by":"publisher","first-page":"e46073","DOI":"10.1371\/journal.pone.0046073","volume":"7","author":"E Merlini","year":"2012","unstructured":"Merlini E, Luzi K, Suardi E, Barassi A, Cerrone M, Mart\u00ednez JS, Bai F, D\u2019Eril GV, Monforte AD, Marchetti G. T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis. PLoS ONE. 2012;7:e46073. [CrossRef] [PubMed].","journal-title":"PLoS ONE"},{"key":"13377_CR35","doi-asserted-by":"publisher","first-page":"116851","DOI":"10.1016\/j.lfs.2019.116851","volume":"235","author":"TF Msoka","year":"2019","unstructured":"Msoka TF, Van Guilder GP, van Furth M, Smulders Y, Meek SJ, Bartlett JA, Vissoci JRN, van Agtmael MA. The effect of HIV infection, antiretroviral therapy on carotid intima-media thickness: A systematic review and meta-analysis. Life Sci. 2019;235:116851. [CrossRef] [PubMed].","journal-title":"Life Sci"},{"key":"13377_CR36","unstructured":"Linton MRF, Yancey PG, Davies SS, et al. The role of lipids and lipoproteins in atherosclerosis. In: Feingold, K.R.; Ah-med, S.F.; Anawalt, B.; et al., Eds. Endotext [Internet]. MDText.com, Inc., South Dartmouth (MA), 2000\u2013. Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK343489\/. (Accessed on January 3, 2019). [PubMed]."},{"key":"13377_CR37","doi-asserted-by":"publisher","first-page":"2215636","DOI":"10.1080\/19932820.2023.2215636","volume":"18","author":"K Yeboah","year":"2023","unstructured":"Yeboah K, Essel S, Agyekum J, Dzudzor B. Association between cardio-ankle vascular index and cardiometabolic risk factors in HIV patients in Ghana. Libyan J Med. 2023;18:2215636. [CrossRef] [PubMed].","journal-title":"Libyan J Med"},{"key":"13377_CR38","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3390\/jcm11071804","volume":"11","author":"E Athanasiadi","year":"2022","unstructured":"Athanasiadi E, Bonou M, Basoulis D, Kapelios CJ, Masoura C, Skouloudi M, Mavrogeni S, Aggeli C, Psichogiou M, Barbetseas J. Subclinical Left Ventricular Systolic Dysfunction in HIV Patients: Prevalence and Associations with Carotid Atherosclerosis and Increased Adiposity. J Clin Med. 2022;11:1804. [CrossRef] [PubMed].","journal-title":"J Clin Med"},{"key":"13377_CR39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/09540121.2022.2029820","volume":"35","author":"A Rerkasem","year":"2023","unstructured":"Rerkasem A, Tangmunkongvorakul A, Aurpibul L, Sripan P, Parklak W, Nantakool S, Srithanaviboonchai K, Rerkasem K. Association of cardio-ankle vascular index and future major adverse cardiovascular events in older adults living with HIV. AIDS Care. 2023;35:591\u20139. [CrossRef] [PubMed].","journal-title":"AIDS Care"},{"issue":"4","key":"13377_CR40","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/QAD.0000000000002794","volume":"35","author":"K Falasca","year":"2021","unstructured":"Falasca K, Lanuti P, Ucciferri C, Pieragostino D, Cufaro MC, Bologna G, Federici L, Miscia S, Pontolillo M, Auricchio A, Del Boccio P, Marchisio M, Vecchiet J. Circulating extracellular vesicles as new inflammation marker in HIV infection. AIDS. 2021;35(4):595\u2013604.","journal-title":"AIDS"},{"key":"13377_CR41","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1186\/s12879-024-09565-w","volume":"24","author":"K Falasca","year":"2024","unstructured":"Falasca K, Ucciferri C, Di Gasbarro A, Borrelli P, Di Nicola M, Frisenda C, Costantini E, Aielli L, Reale M, Vecchiet J. Cytokines assets in PLWH in two-drug dolutergravir based or three-drug antiretroviral regimen. BMC Infect Dis. 2024;24:665.","journal-title":"BMC Infect Dis"},{"key":"13377_CR42","doi-asserted-by":"publisher","first-page":"350","DOI":"10.5414\/CN110377","volume":"95","author":"M Pontolillo","year":"2021","unstructured":"Pontolillo M, Piscitani L, Ucciferri C, Di Liberato L, Bonomini M, Vecchiet J. A rare case of acute tubular necrosis tenofovir alafenamide-related. Clin Nephrol. 2021;95:350\u20132.","journal-title":"Clin Nephrol"},{"key":"13377_CR43","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1021\/acs.molpharmaceut.8b01014","volume":"16","author":"M Velichkovska","year":"2019","unstructured":"Velichkovska M, Surnar B, Nair M, Dhar S, Toborek M. Targeted Mitochondrial COQ 10 Delivery Attenuates Antiretroviral-Drug-Induced Senescence of Neural Progenitor Cells. Mol Pharm. 2019;16:724\u201336.","journal-title":"Mol Pharm"},{"key":"13377_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12981-024-00694-5","volume":"21","author":"F Lombardi","year":"2024","unstructured":"Lombardi F, Belmonti S, Sanfilippo A, Borghetti A, Iannone V, Salvo PF, Fabbiani M, Visconti E, Giambenedetto S. Di Factors Associated with Oxidative Stress in Virologically Suppressed People Living with HIV on Long-Term Antiretroviral Therapy. AIDS Res Ther. 2024;21:100.","journal-title":"AIDS Res Ther"},{"key":"13377_CR45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/aid.2020.0197","volume":"37","author":"CD Lahiri","year":"2021","unstructured":"Lahiri CD, Xu Y, Wang K, Alvarez JA, Sheth AN, O\u2019Halloran J, Spence AB, Tien P, Gustafson DR, Milam J, Fischl MA, Konkle-Parker D, Adimora AA, Sharma A, Weber KM, Ofotokun I, Rubin LH. Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV. AIDS Res Hum Retroviruses. 2021;37:461\u20137. [CrossRef] [PubMed].","journal-title":"AIDS Res Hum Retroviruses"},{"key":"13377_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/QAI.0000000000003101","volume":"92","author":"FJ Palella","year":"2023","unstructured":"Palella FJ, Hou Q, Li J, Mahnken J, Carlson KJ, Durham M, Ward D, Fuhrer J, Tedaldi E, Novak R, Buchacz K. Weight Gain and Metabolic Effects in Persons with HIV Who Switch to ART Regimens Containing Integrase Inhibitors or Tenofovir Alafenamide. J Acquir Immune Defic Syndr. 2023;92:67\u201375. [CrossRef] [PubMed].","journal-title":"J Acquir Immune Defic Syndr"},{"key":"13377_CR47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/cid\/ciae645","volume":"81","author":"AG de Garc\u00eda-Ruiz","year":"2025","unstructured":"de Garc\u00eda-Ruiz AG, Su\u00e1rez Robles M, P\u00e9rez-El\u00edas MJ, Negredo E, Alcam\u00ed J, G\u00f3mez Rodr\u00edguez CE, Gonz\u00e1-lez-Ruano P, de Z\u00e1rraga Fern\u00e1ndez MA, Due\u00f1as Guti\u00e9rrez C, Moreno Guill\u00e9n S, Mart\u00ednez-Sanz J. Metabolic Complications After Initiating BIC\/FTC\/TAF versus DTG\u2009+\u20093TC in Antiretroviral-Therapy-Naive Adults with HIV: A Multicenter Prospective Cohort Study. Clin Infect Dis. 2025;81:263\u201370. [CrossRef] [PubMed].","journal-title":"Clin Infect Dis"},{"key":"13377_CR48","doi-asserted-by":"publisher","first-page":"8852","DOI":"10.3390\/cimb46080523","volume":"46","author":"R Harshithkumar","year":"2024","unstructured":"Harshithkumar R, Shah P, Jadaun P, Mukherjee A. ROS Chronicles in HIV Infection: Genesis of Oxidative Stress, Associated Pathologies, and Therapeutic Strategies. Curr Issues Mol Biol. 2024;46:8852\u201373.","journal-title":"Curr Issues Mol Biol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13377-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13377-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13377-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:02:26Z","timestamp":1781143346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13377-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13377"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13377-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"15 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Sakarya University Faculty of Medicine Clinical Research Ethics Committee (Approval number: 43012747-050.04-399465-14, Date: 2024, Sep. 19). The study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1120"}}